| Invios GmbH. (9/5/23). "Press Release: Invios Starts Further Clinical Trial of APN401, Novel Cell Therapy Against Solid Cancers, and Secures Major Austrian Grant Funding". Vienna. |
2023-09-05 |
| QbD Group. (5/25/23). "Press Release: The QbD Group Acquires Michor Consulting to Enhance Its Regulatory Affairs Services across Europe". |
2023-05-25 |
| aws Gründerfonds. (5/24/23). "Pressemitteilung: aws Gründungsfonds II. Neuer Venture Capital Fonds für innovative Technologien sucht die besten Start-ups". |
2023-05-24 |
| LifeArc. (5/2/23). "Press Release: Dr Jason Slingsby Joins LifeArc as Chief Business Officer". |
2023-05-02 |
| Proxygen GmbH. (4/5/23). "Press Release: Proxygen Announces Collaboration and License Agreement with MSD". Vienna. |
2023-04-05 |
| Proxygen GmbH. (3/15/23). "Press Release: Proxygen Announces Formation of Board of Directors". Vienna. |
2023-03-15 |
| aws Gründerfonds. (12/23/22). "Pressemitteilung: aws Gründerfonds investiert in nachhaltiges Lebensmittel-Startup Arkeon". Tulln & Wien. |
2022-12-23 |
| Sarcura GmbH. (11/17/22). "Press Release: Sarcura Secures € 7M Seed Plus Funding to Revolutionize Cell Therapy Manufacturing". Klosterneuburg. |
2022-11-17 |
| Celeris Therapeutics GmbH. (10/19/22). "Press Release: Celeris Therapeutics to Receive 12.5 Million Euros in Funding from the European Innovation Council". Graz. |
2022-10-19 |
| HeartBeat.bio AG. (10/5/22). "Press Release: HeartBeat.bio Collaborates with Boehringer Ingelheim to Investigate Cardiac Organoids for the Development of New Treatments for People with Heart Diseases". Vienna. |
2022-10-05 |
| Xund Solutions GmbH. (9/29/22). "Press Release: Healthtech Start-up Xund Raises €6m – One of the Largest Seed Rounds to Date in Austria". |
2022-09-29 |
| NLC Ventures Netherlands B.V.. (9/27/22). "Press Release: BioDGraft, an NLC Venture, Sets Out to Eliminate the Need for Vein Harvesting in Bypass Surgeries, Proposing a Solution that Lasts for Life". |
2022-09-27 |
| HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA. |
2022-09-12 |
| Quantro Therapeutics GmbH. (8/3/22). "Press Release: Quantro Therapeutics Collaborates with Boehringer Ingelheim to Develop Drug Candidates Interfering with Transcriptional Regulators". Vienna. |
2022-08-03 |
| Biosynth Carbosynth. (8/2/22). "Press Release: Biosynth Carbosynth to Offer Enzyme Development Following Acquisition of Eucodis Bioscience". Staad. |
2022-08-02 |
| Proxygen GmbH. (6/2/22). "Press Release: Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders". Vienna. |
2022-06-02 |
| Apeiron Biologics AG. (4/26/22). "Press Release: Apeiron Shareholders Approve New Group Structure Geared towards Enabling Innovation and Growth". Vienna. |
2022-04-26 |
| Celeris Therapeutics GmbH. (4/4/22). "Press Release: Celeris Therapeutics and Boehringer Ingelheim Enter Collaboration to Develop Next-generation Targeted Protein Degraders". Menlo Park, CA. |
2022-04-04 |
| European Invesmtent Bank (EIB). (3/24/22). "Press Release: Austria – EIB Supports Innovacell’s Innovative Cell Therapy for Treating Incontinence". |
2022-03-24 |
| Celeris Therapeutics GmbH. (2/24/22). "Press Release: CelerisTx Appoints Pharmaceuticals Industry Leader Peter Ho, M.D., Ph.D., to the Board of Directors". Menlo Park, CA. |
2022-02-24 |
| Marinomed Biotech AG. (2/15/22). "Press Release: Marinomed Receives €6m with Final Tranche of Financing Agreement with EIB to Invest in Proprietary R&D Pipeline". Korneuburg. |
2022-02-15 |
| Celeris Therapeutics GmbH. (2/10/22). "Press Release: CelerisTx Announces $4.4m Financing to Advance Pipeline of Novel Proximity Inducing Compound". Menlo Park, CA. |
2022-02-10 |
| Celeris Therapeutics GmbH. (2/9/22). "Press Release: CelerisTx in Artificial Intelligence Research Collaboration with Merck KGaA, Darmstadt, Germany on AI-enabled Degrader Discovery". Menlo Park, CA. |
2022-02-09 |
| Celeris Therapeutics GmbH. (2/2/22). "Press Release: Celeris Therapeutics, the PIC Engineering Company, Announces the Appointment of Biotech Veterans to Lead Drug Discovery and Biology Efforts". |
2022-02-02 |
| Ribbon Biolabs GmbH. (1/31/22). "Press Release: Ribbon Biolabs Raises EUR 18 Million Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology". Vienna. |
2022-01-31 |
| Cyprumed GmbH. (1/24/22). "Press Release: Cyprumed GmbH Enters Agreement with Ferring Pharmaceuticals for Development of Oral Drug Delivery Technology for Patient-Centric non-invasive Peptide Therapeutics". Innsbruck. |
2022-01-24 |
| Marinomed Biotech AG. (1/21/22). "Press Release: Marinomed Announces the Appointment of Dr. Cornelia Kutzer as Chief Business Officer". Korneuburg. |
2022-01-21 |
| Sanofi S.A.. (12/1/21). "Press Release: Sanofi to Acquire Origimm Biotechnology in First Move to Treat Acne with Vaccine-based Immunotherapy". Paris & Vienna. |
2021-12-01 |
| aws Gründerfonds. (11/23/21). "Press Release: Innerspace Receives Seven-figure Investment". Vienna. |
2021-11-23 |
| EIT Health e.V.. (11/9/21). "Press Release: EIT Health-supported PhagoMed Acquired by BioNTech". |
2021-11-09 |
| Celeris Therapeutics GmbH. (11/1/21). "Press Release: Celeris Therapeutics, the Pioneer in AI-driven Degrader Design, Builds Laboratories in Austria". Graz. |
2021-11-01 |
| Boehringer Ingelheim. (10/6/21). "Press Release: Boehringer Ingelheim Inaugurates Biopharmaceutical Production Facility in Vienna, Austria". Ingelheim. |
2021-10-06 |
| Hookipa Pharma Inc.. (10/6/21). "Press Release: Groundbreaking Ceremony for Hookpia’s New Production Site". Vienna. |
2021-10-06 |
| Delta 4 GmbH. (9/27/21). "Press Release: Delta4 Announces Dr. Hans Lehrach to Join Scientific Advisory Board". Vienna. |
2021-09-27 |
| Celeris Therapeutics GmbH. (8/27/21). "Press Release: Celeris Therapeutics Welcomes Life Sciences and Technology Thought Leader Ian Marks as a Non-Executive Director". Menlo Park, CA. |
2021-08-27 |
| AC Immune S.A.. (7/27/21). "Press Release: AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH". Lausanne. |
2021-07-27 |
| High-Tech Gründerfonds Management GmbH. (7/5/21). "Press Release: Cutanos Closes First Financing Round with Investor Consortium from Austria and Germany". Vienna. |
2021-07-05 |
| Max Planck Innovation GmbH. (7/5/21). "Press Release: Targeted Immune Stimulation for more Effective Vaccines. Cutanos, a Spin-off from the Max Planck Society, Is Developing Novel Vaccines and Immunotherapies". |
2021-07-05 |
| Delta 4 GmbH. (6/25/21). "Press Release: Alfred Steininger to Join Delta4 as CFO". |
2021-06-25 |
| Exscientia Ltd.. (6/15/21). "Press Release: Exscientia Acquires Personalised Medicine AI Pioneer Allcyte". |
2021-06-15 |
| BASF SE. (5/3/21). "Press Release: BASF Strengthens Its Global Production Footprint for Enzymes. BASF Will Invest at Novartis’ Kundl/Schaftenau Campus, in Austria". |
2021-05-03 |
| Delta 4 GmbH. (4/7/21). "Press Release: Delta 4 Announces Closing of Multi-million Series A Financing Round". Vienna. |
2021-04-07 |
| Allcyte GmbH. (3/25/21). "Press Release: Austrian Biotech Allcyte Raises $6m Seed Round Following Breakthrough Cancer Clinical Trial". |
2021-03-25 |
| Chemieanlagenbau Chemnitz GmbH. (3/1/21). "Press Release: CAC Builds Biofuel Plant for OMV in Schwechat (A)". Chemnitz. |
2021-03-01 |
| Sarcura GmbH. (3/21). "Press Release: Sarcura Received a 1.5 m € Research Grant from FFG". |
2021-03-01 |
| Resolve Biosciences GmbH. (2/22/21). "Press Release: Resolve Biosciences Announces Initial Results from Early Access Collaborations with Scientists Leading the Next Generation of Subcellular Spatial Analysis". Monheim am Rhein. |
2021-02-22 |
| Novartis AG. (2/11/21). "Press Release: Sandoz Announces Agreement to Acquire GSK’s Cephalosporin Antibiotics Business, Reinforcing Its Leading Global Position in Antibiotics". Basel. |
2021-02-11 |
| Sarcura GmbH. (1/31/21). "Press Release: Sarcura and imec to Collaborate on High Throughput Cytometry Solution for Automated (T-)Cell Separation, Tackling Manufacturing Challenges of CGT". Klosterneuburg & Leuven. |
2021-01-31 |
| Biotech Austria. (12/10/20). "Press Release: Austria’s Biotechnology Companies Establish Biotech Austria – Biotech Industry Association". Vienna. |
2020-12-10 |
| OpGen, Inc.. (12/9/20). "Press Release: OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics". Gaithersburg, MD & Vienna. |
2020-12-09 |
| Boehringer Ingelheim. (12/7/20). "Press Release: Boehringer Ingelheim Collaborates with Proxygen to Explore Molecular Glue Degraders – a Novel Approach to Fight Cancer". Ingelheim & Vienna. |
2020-12-07 |
| Sarcura GmbH. (11/19/20). "Press Release: Sarcura Raises a 2.5 M€ Seed Round. Start-up Advances Their Transformative Manufacturing Platform for Autologous Cell Therapies". Klosterneuburg. |
2020-11-19 |
| Apeiron Biologics AG. (11/9/20). "Press Release: Apeiron Biologics AG and Domainex Ltd Announce the Expansion of Their Partnership to Progress Targeted Cancer Immune Therapy Drug Discovery". Vienna & Saffron Waldon. |
2020-11-09 |
| Biosynth Carbosynth. (11/3/20). "Press Release: Biosynth Carbosynth Expands Its Enzyme Offerings with Products for Industrial Applications". |
2020-11-03 |
| Proxygen GmbH. (7/31/20). "Press Release: Boehringer Ingelheim Awards Proxygen with BI Innovation Prize". Vienna. |
2020-07-31 |
| Quantro Therapeutics GmbH. (7/21/20). "Press Release: Quantro Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform". Vienna. |
2020-07-21 |
| DeepSpin GmbH. (6/30/20). "Press Release: Berlin-based DeepSpin Raises Seed Round to Revolutionize Medical Imaging". Berlin. |
2020-06-30 |
| Apeiron Biologics AG. (6/3/20). "Press Release: Apeiron Biologics Closes Oversubscribed Financing Round of EUR 17.5 Million for the Development of APN01 against COVID-19". Vienna. |
2020-06-03 |
| Delta 4 GmbH. (6/2/20). "Press Release: Delta 4 Announces Results Achieved with Drug Discovery Platform". Vienna. |
2020-06-02 |
| Merck & Co., Inc.. (5/26/20). "Press Release: Merck to Acquire Themis". Kenilworth, NJ. |
2020-05-26 |
| Apeiron Biologics AG. (5/18/20). "Press Release: Apeiron Biologics Announces Financing Round for the Further Development of the COVID-19 Drug APN01". Vienna. |
2020-05-18 |
| Apeptico Forschung und Entwicklung GmbH. (4/7/20). "Press Release: Solatide Has Been Approved by the Austrian Federal Office for Safety in Health Care for the Treatment of COVID-19 Patients with Severe Pulmonary Dysfunction". Vienna. |
2020-04-07 |
| Evotec SE. (4/6/20). "Press Release: Evotec Expands into Gene Therapy. Evotec Establishes Gene Therapy R&D Site with more than 20 Experienced Scientis in Austria". Hamburg. |
2020-04-06 |
| Evotec SE. (4/6/20). "Press Release: Evotec and Takeda Enter into Multi-year Gene Therapy Research Alliance". Hamburg. |
2020-04-06 |
| Apeiron Biologics AG. (4/2/20). "Press Release: Apeiron Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19". Vienna. |
2020-04-02 |
| OncoOne GmbH. (3/18/20). "Press Release: OncoOne Launches with EUR 13 Million Series A to Develop Multiple Drug Modalities for Unexplored Target". Klosterneuburg. |
2020-03-18 |
| Calyxha Biotechnologies GmbH. (3/4/20). "Press Release: Calyxha Endeavors to Develop Novel Approaches to Tissue Degenerative Diseases and Receives Support from Austrian VC and International Investors". Vienna. |
2020-03-04 |
| ERS Genomics Ltd.. (2/11/20). "Press Release: ERS Genomics and Aelian Biotechnology Announce CRISPR/Cas9 License Agreement Enabling Aelian’s Unique Screening Platform". Dublin & Vienna. |
2020-02-11 |
| CellTool GmbH. (1/20/20). "Press Release: CellTool Appoints Wulf Fischer-Knuppertz as CEO". Tutzing. |
2020-01-20 |
| Innate Pharma S.A.. (12/13/19). "Press Release: Innate Pharma Provides Update on Lacutamab TELLOMAK Trial". Marseille. |
2019-12-13 |
| SHS Gesellschaft für Beteiligungsmanagement mbH. (11/26/19). "Press Release: Establishing a New Standard for the Life Science Industry. SHS Supports Internationalization and Further Growth of Single Use Support". Tübingen & Kufstein. |
2019-11-26 |
| Themis Bioscience GmbH. (10/29/19). "Press Release: Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine". Vienna & Oslo. |
2019-10-29 |
| Curetis N.V.. (10/28/19). "Press Release: Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test". Vienna & Holzgerlingen. |
2019-10-28 |
| PhagoMed Biopharma GmbH. (10/22/19). "Press Release: Phage Lysin Stabilzes Vaginal Microbiome. PhageMed Accelerates R6D Program against Bacterial Vaginosis". Vienna. |
2019-10-22 |
| Blueprint Genetics Oy. (9/24/19). "Press Release: Blueprint Genetics and ArchimedLife Form a Partnership to Launch High Quality Biochemical Testing for Rare Diseases in North America". |
2019-09-24 |
| Themis Bioscience GmbH. (9/18/19). "Press Release: Themis Raises EUR 40 Million in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline". Vienna. |
2019-09-18 |
| Curetis N.V.. (9/16/19). "Press Release: Curetis Group Subsidiary Ares Genetics Signs R&D and Option Agreement with Leading Global IVD Corporation". Holzgerlingen & Vienna. |
2019-09-16 |
| Biocrates Life Sciences AG. (9/12/19). "Press Release: Repositioning of Biocrates – Management Change and New Round of Financing". Innsbruck. |
2019-09-12 |
| Themis Bioscience GmbH. (8/22/19). "Press Release: Themis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates". Vienna. |
2019-08-22 |
| Curetis N.V.. (8/8/19). "Press Release: Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing". Vienna & Holzgerlingen. |
2019-08-08 |
| IMBA – Institute of Molecular Biotechnology GmbH. (8/7/19). "Press Release: a:head bio – Launched to Transform CNS Drug Discovery". |
2019-08-07 |
| Platomics GmbH. (8/6/19). "Press Release: 7-digit Investment in Future Technology Genetic Testing". |
2019-08-06 |
| PhagoMed Biopharma GmbH. (6/27/19). "Press Release: Further Investment for PhagoMed. Investors Support Phage Therapy". Vienna. |
2019-06-27 |
| Themis Bioscience GmbH. (6/4/19). "Press Release: CEPI Awards up to US$21 Million to Themis Bioscience for Phase 3 Chikungunya Vaccine Development". Vienna & Oslo. |
2019-06-04 |
| ERS Genomics Ltd.. (4/23/19). "Press Release: US Patent Office Grants Charpentier/Doudna Key CRISPR Patent". Dublin. |
2019-04-23 |
| Curetis N.V.. (4/12/19). "Press Release: Curetis’ Subsidiary Ares Genetics Introduces NGS Services for Pharma and Public Health Sector at Upcoming ECCMID 2019". Vienna, Holzgerlingen & Amsterdam. |
2019-04-12 |
| Curetis N.V.. (4/4/19). "Press Release: Study Data Presented at ECCMID 2019 Confirm Clinical Benefits of Unyvero Platform". Amsterdam, San Diego, CA & Holzgerlingen. |
2019-04-04 |
| Curetis N.V.. (4/2/19). "Press Release: Curetis Introduces Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance". Amsterdam & Holzgerlingen. |
2019-04-02 |
| Themis Bioscience GmbH. (2/25/19). "Press Release: Themis Bioscience Receives FDA Fast Track Designation for Chikungunya Vaccine Candidate". Vienna. |
2019-02-25 |
| Curetis N.V.. (2/18/19). "Press Release: Curetis’ Subsidiary Ares Genetics and Qiagen Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance". Vienna, Holzgerlingen & Amsterdam. |
2019-02-18 |
| Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Sets Offer Price at 75 Euro per Share (Adhoc-News)". |
2019-01-29 |
| Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Announces Strong Investor Demand and Expected Offer Price (Adhoc-News)". |
2019-01-29 |
| Marinomed Biotech AG. (1/23/19). "Press Release: Marinomed Resumes Offer Period of the IPO (Adhoc-News)". |
2019-01-23 |
| Marinomed Biotech AG. (1/21/19). "Press Release: Partnership in China and EIB Financing [Not for US, AU, CA, JP or any other jurisdiction where prohibited by applicable law]". Vienna. |
2019-01-21 |
| Curetis N.V.. (1/8/19). "Press Release: Curetis’ Subsidiary Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test". Vienna, Amsterdam & Holzgerlingen. |
2019-01-08 |
| Valneva S.E.. (1/7/19). "Press Release: Valneva Announces Its Intention to Delist from the Vienna Stock Exchange. Trading Will Be Centralized on Euronext Paris". Saint-Herblain. |
2019-01-07 |
| Curetis N.V.. (12/18/18). "Press Release: Curetis’ Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance". Vienna, Holzgerlingen & Amsterdam. |
2018-12-18 |
| Bruker Corporation. (12/18/18). "Press Release: Bruker Completes the Acquisition of Alicona Imaging GmbH". Billerica, MA. |
2018-12-18 |
| Curetis N.V.. (12/13/18). "Press Release: Curetis Sharpens Focus on Near-term Strategic Value Drivers. Business Focus on U.S. Commercialization, Strategic Partnering, Ares Genetics and Asset Monetization". Amsterdam, Holzgerlingen & San Diego, CA. |
2018-12-13 |
| SGS S.A.. (12/12/18). "Press Release: SGS Invests in Imprint Analytics, Austria". |
2018-12-12 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
